Predictors of Viral Suppression among Adults Living with HIV/AIDS in Nigeria: A Retrospective Chart Review
Annals of African Medicine · 2024
DOI: 10.4103/aam.aam_42_23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of African Medicine, 2024. Verfasst von Ibrahim Abayomi Ogunyinka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, Usmanu Danfodiyo University Sokoto, Sokoto, Nigeria. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents, Viral Load. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Information: Over 1.6 million Nigerians have succumbed to the ravaging scourge of the acquired immunodeficiency syndrome (AIDS) epidemic since its discovery. Viral suppression (VS) then becomes a critical cost-effective human immunodeficiency virus (HIV) prevention strategy. We assessed the prevalence and predictors of VS. Materials and Methods: This retrospective case file review was conducted among adults (aged ≥18 years) living with HIV/AIDS who accessed care at a tertiary health facility in Northwestern Nigeria between January and December 2021.
Results
One thousand one hundred and twenty HIV/AIDS-eligible patients accessed care during the study. Their age ranged between 20 and 70 years with a mean of 43.83 ± 10.83 (95% confidence interval [CI]: 43.19–44.46). The patients were mostly female (728; 65.0), residing in urban areas (680; 60.7%), self-employed (440; 39.3%), married (712; 63.6%), receiving antiretroviral therapy (ART) for at most 14 years (916; 81.8%), on first-line ART regimen (812; 72.5%), in HIV clinical stage 1 (964; 86.1%), and with a baseline CD4 count of 199 cells/µl (453; 40.4%). The prevalence of VS of 64.3% (720/1120) was recorded in the study. The predictors of VS were disclosure of HIV status (odds ratio [OR] =2.4; 95% CI = 1.503–3.832), absence of opportunistic infections (OR = 2.6; 95% CI = 1.242–5.406), receiving ART for 15–29 years (OR = 2.1; 95% CI = 1.398–3.292), first-line ART regimen (OR = 3.7; 95% CI = 2.618–5.115), and adequate adherence (OR = 4.7; 95% CI = 3.324–6.766).
Conclusion
VS was suboptimal among the study cohort with adequate adherence being its strongest predictor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, Usmanu Danfodiyo University Sokoto, Sokoto, Nigeria.
- Department of Pharmacy, Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria.
- Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, Usmanu Danfodiyo University Sokoto, Sokoto, Nigeria.
- Department of Medical Microbiology and Parasitology, Usmanu Danfodiyo University Sokoto, Sokoto, Nigeria.
- Department of Family Medicine, Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria.
Zitieren
APA
Ogunyinka, I. A., Shaibu, R. O., Abubakar, K., Yahaya, M., Chukwudi, U. E., Usman, M. L., & Abdulazeez, L. A. (2024). Predictors of Viral Suppression among Adults Living with HIV/AIDS in Nigeria: A Retrospective Chart Review. Annals of African Medicine. https://doi.org/10.4103/aam.aam_42_23
Vancouver
Ogunyinka IA, Shaibu RO, Abubakar K, Yahaya M, Chukwudi UE, Usman ML, et al. Predictors of Viral Suppression among Adults Living with HIV/AIDS in Nigeria: A Retrospective Chart Review. Annals of African Medicine. 2024. doi:10.4103/aam.aam_42_23
BibTeX
@article{Ogunyinka2024,
author = {Ogunyinka, Ibrahim Abayomi and Shaibu, Rita Ojochide and Abubakar, Kabiru and Yahaya, Mohammed and Chukwudi, Udegbunam Emmanuel and Usman, Muhammad Liman and Abdulazeez, Lubabatu Abdulkadir},
title = {Predictors of Viral Suppression among Adults Living with HIV/AIDS in Nigeria: A Retrospective Chart Review},
journal = {Annals of African Medicine},
year = {2024},
doi = {10.4103/aam.aam_42_23}
}
EUVIMED